Older Adults, Methadone, and Cognitive Function

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age55+
SponsorUniversity of Maryland, Baltimore

About this trial

The increasing prevalence of opioid use disorder (OUD) among older adults, coupled with high overdose rates and cognitive impairments associated with opioid use, highlights a critical gap in addiction treatment. Cognitive impairments can persist despite treatment and negatively impact recovery outcomes, yet cognitive screening and interventions are rarely integrated into OUD care. This study aims to evaluate the feasibility of remotely delivered, smartphone-based cognitive assessments (administered through NeuroUX web-based software) for older adults (55+) in methadone treatment. The tasks have been "gamified" to make them engaging and brief, which could be appealing to patients. They will complete the tasks for 15 days using the phone provided or their own phone. During days 6-15 of testing, tasks will become incrementally more difficult based on participant performance to assess the feasibility of cognitive training. Cognitive training uses engaging games or tasks to strengthen thinking skills like memory and focus, much like physical exercise strengthens the body. Adherence, acceptability, and usability of the tasks will be assessed. Secondary analyses will explore relationships between task performance and participant characteristics (e.g., baseline cognitive functioning, methadone dose, timing of methadone dose). Findings from this pilot study will provide foundational data for a future grant application to develop and test digital cognitive assessment and training interventions tailored to older adults in addiction treatment. By addressing a critical yet understudied aspect of OUD care this research has the potential to enhance treatment engagement, improve clinical outcomes, and support long-term recovery in the growing older population.

Eligibility criteria

Qualifiers

age 55 and older

currently in outpatient methadone treatment for opioid use disorder

participant is alert/able to communicate/able to give acceptable answers on the "Evaluation to Sign Consent form

participant has normal or correct to normal vision

Disqualifiers

age 54 or younger

not in methadone treatment for opioid use disorder

Trial design

Treatments tested in this trial

  • Smartphone based cognitive tasks

Treatment groups

30 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Maryland, Baltimore

Lead sponsor

National Institute on Aging (NIA)

Collaborator